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Bacimethrin is an analog of the 4-amino-5-hydroxymethyl-2-methylpyrimidine (HMP) moiety of thiamine
and inhibits the growth of Salmonella enterica serovar Typhimurium on a defined medium. Two classes of
mutants that had increased bacimethrin resistance were isolated and characterized. Results showed that over-
expression of the thi operon or specific lesions in thiD resulted in a bacimethrin-resistant phenotype. Pheno-
typic analyses of the thiD mutants suggested that they had a specific defect in one of the two kinase activities
associated with this gene product and, further, that ThiD and not PdxK was primarily responsible for salvage
of HMP from the medium.
Thiamine is synthesized de novo by many bacteria. Although
the general outline of the thiamine biosynthetic pathway in
enteric microorganisms is known, the individual reactions in
this pathway are not yet fully understood. Thiamine pyrophos-
phate (TPP), the biologically active cofactor, is generated by
the condensation of two independently synthesized intermedi-
ates, 4-methyl-5-(b-hydroxyethyl)thiazole (THZ) phosphate
and 4-amino-5-hydroxymethyl-2-methylpyrimidine (HMP) py-
rophosphate. In vivo labeling studies demonstrated that the
carbon atoms in HMP were derived from the purine interme-
diate aminoimidazole ribonucleotide (AIR), although the bio-
chemical details of this conversion have not been elucidated
(2). Mutations causing an unconditional requirement for ex-
ogenous HMP or thiamine map to a single gene, thiC. In vivo
labeling also determined the metabolic precursors to the THZ
moiety, and several genes have been implicated in this synthe-
sis (2, 18). Our current understanding of the synthesis and
salvage of TPP is presented in Fig. 1.
While the low cellular requirement for thiamine has com-
plicated the detailed analysis of its biosynthetic pathway, this
characteristic has made thiamine synthesis an attractive model
system for dissecting the integration of metabolic pathways
(25). Characterization of mutations that perturbed, but did not
eliminate, thiamine synthesis has resulted in the identification
of a number of loci required for optimal synthesis of this
vitamin and has increased our understanding of the integration
of thiamine biosynthesis with central cellular processes (1, 5, 6,
8, 10–12, 24b, 25, 27).
Use of metabolic inhibitors, or analogs, has provided insight
in the studies of a number of metabolic pathways, including
histidine (17), folate (3), and branched-chain amino acids (19–
21). Bacimethrin is a thiamine antagonist produced by gram-
positive bacteria, including Streptomyces albus (7) and Bacillus
megaterium (29) (Fig. 1). Previous reports showed that the
inhibitory effect of bacimethrin on defined medium could be
overcome by exogenous addition of thiamine or the HMP
moiety (7).
Wild-type Salmonella enterica serovar Typhimurium strain
LT2 was unable to grow on solid minimal medium in the
presence of 130 nM bacimethrin, and resistant mutants arose
spontaneously at a frequency of ;1027 (data not shown).
Growth of the wild-type strain was restored by the addition of
either HMP or thiamine, indicating a specific antagonism for
the pyrimidine moiety of thiamine (7). Mutations allowing the
growth of LT2 in the presence of 130 nM bacimethrin were
isolated, either spontaneously or following localized chemical
mutagenesis (15), in the thi loci at 90 min (thiCEFSGH) and 46
min (thiMD).
Increased transcription of the thiCEFSGH operon results in
bacimethrin resistance. Two bacimethrin-resistant mutants
with causative lesions at 90 min on the chromosome were
characterized to determine if expression of the thiCEFSGH
operon was altered. A DNA fragment containing the 400 bp
upstream of the thiC initiating codon was PCR amplified from
wild-type strain LT2 and bacimethrin-resistant strains DM4078
(thi-1132) and DM4081 (thi-1133). The resulting fragments
were ligated in front of the promoterless lacZ gene in pKC1
(4), generating plasmids pThi, pThi4, and pThi8, respectively.
Strains containing these plasmids, grown on medium in the
presence or absence of thiamine, were assayed for b-galacto-
sidase activity and the results are shown in Table 1. Two points
could be made from these data: (i) transcription from the
mutant constructs was three- to fourfold increased compared
to the wild-type construct, and (ii) in both the wild-type and
mutant constructs, exogenous thiamine repressed transcrip-
tion. These results suggested that the causative mutations af-
fected primarily promoter strength rather than regulation of
the operon.
To confirm that increased expression of the thiCEFSGH
operon was responsible for the bacimethrin-resistant pheno-
type of these strains, a multicopy plasmid carrying the entire
thiCEFSGH operon from Escherichia coli was electroporated
into strain LT2. This plasmid, pVJS717 (30), and not the par-
ent plasmid (pGEM) allowed growth in the presence of 130
nM bacimethrin. Since bacimethrin is structurally similar to
HMP, ThiC and ThiE were potential targets for inhibition. To
address whether overexpression of thiC or thiE alone was suf-
ficient to cause bacimethrin resistance, multicopy plasmids
containing either thiC (pThiC) or thiE (pThiE) were gener-
ated, with expression of the thi gene from the lacZ promoter of
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pSU19 (22). Neither strain DM5717 (LT2/pThiE) nor strain
DM5654 (LT2/pThiC) was able to grow on solid medium in the
presence of 130 nM bacimethrin. These results suggested ei-
ther that expression of the respective genes from the lacZ
promoter in these constructs was not high enough or that
overexpression of more than one gene was required to gener-
ate the bacimethrin-resistant phenotype.
Mutations in thiD can result in a bacimethrin-resistant
phenotype. Two bacimethrin-resistant strains whose lesions
mapped to 46 min on the S. enterica chromosome were exam-
ined in detail (Table 2). Single gene clones of the mutant
alleles were generated by PCR amplifying thiD from the chro-
mosome of DM2983 (thiD1126) and DM4147 (thiD1125) and
ligating it into pSU19, resulting in plasmids pThiD1126 and
pThiD1125, respectively. Each plasmid was electroporated
into a strain carrying a null mutation in thiD (DM456). Both of
the resulting strains (DM5556 and DM5557), but not a strain
with a plasmid carrying the wild-type thiD gene, were able to
grow on solid minimal medium in the presence of 130 nM
bacimethrin. These results demonstrated that the bacimethrin-
resistant mutations in strains DM2983 and DM4147 were al-
leles of thiD. Sequence analyses of plasmids pThiD1126 and
pThiD1125 identified a single base change in each ThiD coding
sequence that would result in the amino acid changes P186Q
and N15S, respectively.
The thiD gene product has been shown to catalyze two
kinase reactions relevant to thiamine biosynthesis (2, 24a).
Since both the original bacimethrin-resistant thiD mutants and
the plasmid-containing strains were prototrophic, we con-
cluded that the HMP-P kinase activity of ThiD required for de
novo thiamine synthesis was present.
Increased bacimethrin resistance could theoretically result
from mutant forms of ThiD with increased catalytic activity or
FIG. 1. Biosynthetic and salvage pathways for thiamine. The biosynthetic and salvage pathways for thiamine in S. enterica, including gene products where known,
is represented. The structure of bacimethrin is shown in the inset. TMP, thiamine monophosphate. Other terms are as defined in the text.
TABLE 1. thi promoter region from bacimethrin-resistant
mutants directs increased expressiona
Plasmid
b-Galactosidase
activityb 6 SD Fold
repression
Without thiamine With thiamine
pThi 2,402 6 219 756 6 31 3.2
pThi4 8,947 6 1,303 1,685 6 353 5.3
pThi8 8,933 6 1,825 2,036 6 515 4.4
a Derivatives of LT2 containing the indicated plasmid were grown overnight in
minimal medium containing chloramphenicol and subcultured into minimal me-
dium with or without thiamine. Subcultures were grown to 0.3 to 0.4 A650 before
being assayed. b-Galactosidase activity was assayed as previously described (9,
24), except that volumes were reduced 10-fold, and absorbance was read in a
microtiter plate by a Spectramax Plus (Molecular Devices).
b Activities are reported as nanomoles of o-nitrophenyl-b-D-galactopyranosi-
dase hydrolyzed/minute/A650 6 1 standard deviation of the mean.
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increased substrate specificity. In both of these scenarios, the
mutant thiD would be dominant to wild type. However, when
plasmids pThiD1126 and pThiD1125 were electroporated into
LT2, the resulting strains remained sensitive to bacimethrin,
indicating that the mutant alleles of thiD were recessive. We
reasoned that loss of the HMP kinase, but not the HMP-P
kinase activity of ThiD, would eliminate the initial phosphor-
ylation of bacimethrin, preventing it from interfering with thi-
amine synthesis (T. Begley, personal communication). This
scenario predicted that the bacimethrin-resistant thiD mutants
would be defective in the incorporation of exogenous HMP to
thiamine. To address this, de novo HMP synthesis was blocked
in strains containing thiD1125, thiD1126, and the wild-type
strain LT2 by introducing a purG insertion mutation (Fig. 1).
The minimal concentration of HMP required for growth of the
resulting strains was determined. As shown by the data in
Table 3, each of the strains containing a bacimethrin-resistant
allele of thiD required an increased amount of HMP (com-
pared to the purG mutant) for growth. Specifically, the thiD1125-
containing strain required 100-fold more HMP than the purG
single mutant. It was noted that the mutant most resistant to
bacimethrin (DM2983, containing thiD1126) did not contain
the allele that caused the most dramatic increase in HMP
requirement (thiD1125 in DM5570). There are a number of
formal possibilities to explain this apparent inconsistency,
including different affinities for HMP compared to baci-
methrin.
These results strongly suggested that thiD alleles resulting in
bacimethrin resistance were specifically defective in the HMP
kinase activity. If confirmed by in vitro kinetic analyses of the
mutant proteins, this model provides a positive selection for
thiD mutants defective in one of the two kinase activities and
supports the prediction that the active sites for the two phos-
phorylation reactions would be quite different (26).
A role for PdxK in HMP salvage? The prediction that the
phenotypes shown in Tables 2 and 3 were caused by lack of
HMP kinase activity caused us to consider the role of PdxK in
HMP salvage. The pdxK gene was identified by the role of its
gene product in the salvage of pyridoxine in the synthesis of
pyridoxal 59-phosphate synthesis (30). The in vitro analysis of
PdxK demonstrated that it phosphorylated HMP with the same
general kinetic parameters as it had for pyridoxine (26). Fur-
ther, the Km for HMP of PdxK was ;5-fold lower, and the
kcat/Km ratio was 10-fold higher than the same parameters of
ThiD, suggesting that in vivo PdxK would play a major role
in HMP salvage (26, 30). The identification of mutations in
thiD that resulted in a significantly increased requirement
for HMP in strains carrying a wild-type pdxK locus suggested
that if PdxK plays a role in HMP salvage, it is a minor one.
Sensitivity to bacimethrin reflects flux through the HMP
branch of the thiamine biosynthetic pathway. From the above
results it was formally possible that bacimethrin uptake was
inhibited by HMP and that its target was at a different meta-
bolic step. A correlation of endogenous HMP synthesis and
bacimethrin resistance would eliminate this possibility. Strains
not auxotrophic for thiamine but likely to have increased or
decreased HMP synthesis were assessed for bacimethrin resis-
tance. The growth data from some of these analyses are pre-
sented in Fig. 2 and indicated that the sensitivity of a strain to
bacimethrin correlated with the anticipated flux through the
HMP biosynthetic pathway. The growth of wild-type strain
LT2 in liquid minimal medium was not significantly affected by
516 nM bacimethrin (Fig. 2A). The difference in effective con-
centrations on a solid medium versus a liquid medium was
noted but was not pursued since the strain differences were
qualitatively the same in the two media.
Exogenous addition of purines to the growth medium has
been shown to reduce flux through the biosynthetic pathway
;90%, due to the combined transcriptional and allosteric reg-
ulatory effects of purines on the pathway (14, 16, 23, 31). This
flux reduction does not generate a requirement for thiamine in
a wild-type strain (J. Zilles and D. M. Downs, submitted for
publication). When purines (e.g., adenine) were included in
the growth medium, wild-type LT2 was more sensitive to baci-
methrin (Fig. 2B). A purE mutant, blocked immediately after
the purine-thiamine branch point, was not sensitive to baci-
methrin under the same conditions (Fig. 2C) (25).
This analysis was extended to mutants with a less-character-
ized effect on HMP synthesis. Mutations in panE reduce inter-
nal coenzyme A pools 10-fold, which results in a thiamine
requirement only if flux through the purine pathway is also
reduced (11). When panE mutants are grown on minimal me-
dium, no growth defect is measurable, and internal metabolite
pools of TPP are wild type (11). However, as shown in Fig. 2D,
the panE mutant was sensitive to bacimethrin. A similar re-
sponse was found with an apbC mutant that is thought to be
defective in HMP synthesis (Fig. 2E) (13, 24b). Taken to-
gether, these results suggest that bacimethrin sensitivity can
provide a qualitative measure of flux through the HMP bio-
synthetic pathway.
Conclusions. Results from this study have increased our
understanding of the antagonistic effects of bacimethrin in S.
enterica by identifying two distinct lesions resulting in resis-
tance to this analog. We showed that increased expression of
the thi operon or specific lesions in thiD allow cells to grow in
the presence of increased bacimethrin. Phenotypic analysis of
the thiD mutants suggested that the mutant proteins were
defective in one of the two kinase activities associated with this
protein. Analyses of these mutants suggested that the HMP-
kinase activity of PdxK was the primary route for HMP salvage
(26).
We thank T. Begley for providing us with bacimethrin and for
TABLE 2. Phenotype of bacimethrin-resistant mutants
Strain Genotype
Zone of inhibition (cm)
with bacimethrina:
0.13 1.3
LT2 Wild type 2.4 3.4
DM2983 thiD1126 0 0.2
DM4147 thiD1125 0 0.5
a The diameter of the zone of inhibition was measured when 1 or 10 ml,
containing 0.13 or 1.3 pmol of bacimethrin, respectively, was spotted onto a soft
agar overlay of cells on minimal medium.
TABLE 3. Bacimethrin-resistant mutants have increased
requirement for exogenous HMP
Strain Genotype
Diam of growth (cm) after
addition of HMP a:
100 50 10 5 1 0.5
DM40 purG 3.2 3.0 2.3 2.0 0.8 0.7b
DM5571 purG thiD1126 2.7 2.1 1.2 1 NG NG
DM5570 purG thiD1125 1.6 0.9 NG NG NG NG
a Diameter of growth zone resulting from the addition of the indicated amount
of HMP (in picomoles) to a soft agar overlay of cells on minimal medium
containing 0.4 mM adenine. NG, no growth.
b Strain DM40 (purG) failed to grow with 0.1 pmol of HMP.
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